<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>TB R&#38;D Matters Blog &#187; advocacy</title>
	<atom:link href="http://www.newtbdrugs.org/blog/tag/advocacy/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.newtbdrugs.org/blog</link>
	<description>Working Towards a Faster Cure for Tuberculosis</description>
	<lastBuildDate>Sat, 19 May 2012 12:57:01 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>Watch Video from the World TB Day Congressional Briefing</title>
		<link>http://www.newtbdrugs.org/blog/watch-video-from-the-world-tb-day-congressional-briefing/</link>
		<comments>http://www.newtbdrugs.org/blog/watch-video-from-the-world-tb-day-congressional-briefing/#comments</comments>
		<pubDate>Tue, 01 May 2012 18:02:10 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Announcements]]></category>
		<category><![CDATA[Events]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[advocacy]]></category>
		<category><![CDATA[aeras]]></category>
		<category><![CDATA[crisis]]></category>
		<category><![CDATA[diagnostics]]></category>
		<category><![CDATA[drug discovery]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[stop tb]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[usa]]></category>
		<category><![CDATA[usaid]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3780</guid>
		<description><![CDATA[A briefing and update on tuberculosis (TB), a disease that is curable but still takes the lives of 4,000 people each day and is the number one killer of people living with HIV.  Links to video included.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/watch-video-from-the-world-tb-day-congressional-briefing/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Community Engagement through Drama</title>
		<link>http://www.newtbdrugs.org/blog/community-engagement-through-drama/</link>
		<comments>http://www.newtbdrugs.org/blog/community-engagement-through-drama/#comments</comments>
		<pubDate>Tue, 17 Apr 2012 17:16:46 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Faces of TB]]></category>
		<category><![CDATA[TB Patient Perspective]]></category>
		<category><![CDATA[TB R&D Spotlight Interviews]]></category>
		<category><![CDATA[TB Stigma]]></category>
		<category><![CDATA[Voices from the Fight to Stop Tuberculosis]]></category>
		<category><![CDATA[WGND Podcast Series]]></category>
		<category><![CDATA[advocacy]]></category>
		<category><![CDATA[community]]></category>
		<category><![CDATA[community engagement]]></category>
		<category><![CDATA[education]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[mdr]]></category>
		<category><![CDATA[podcast]]></category>
		<category><![CDATA[social impact]]></category>
		<category><![CDATA[South Africa]]></category>
		<category><![CDATA[tb/hiv]]></category>
		<category><![CDATA[voices]]></category>
		<category><![CDATA[youth empowerment]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3729</guid>
		<description><![CDATA[Dr. Gill Black is the co-founder and Director of Health and Welfare at The Sustainable Livelihoods Foundation (SLF).  In this inteview, we discuss with Dr. Black one of SLF's groundbreaking projects that uses drama to engage local communities around issues related to TB and HIV/AIDS.  ]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/community-engagement-through-drama/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Working Group on New TB Drugs Launches Strategic Plan 2011-2015</title>
		<link>http://www.newtbdrugs.org/blog/working-group-on-new-tb-drugs-launches-strategic-plan-2011-2015/</link>
		<comments>http://www.newtbdrugs.org/blog/working-group-on-new-tb-drugs-launches-strategic-plan-2011-2015/#comments</comments>
		<pubDate>Thu, 29 Mar 2012 15:12:38 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Announcements]]></category>
		<category><![CDATA[TB Drug Development]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[advocacy]]></category>
		<category><![CDATA[community]]></category>
		<category><![CDATA[drug discovery]]></category>
		<category><![CDATA[funding]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[r&d]]></category>
		<category><![CDATA[stop tb]]></category>
		<category><![CDATA[wgnd]]></category>
		<category><![CDATA[WHO]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3680</guid>
		<description><![CDATA[The WGND Strategic Plan 2011-2015 is an update of the "New Drugs" section of the Global Plan to Stop TB: 2011-2015. It describes the progress, gaps, and vision of the WGND and the TB drug development field as a whole. ]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/working-group-on-new-tb-drugs-launches-strategic-plan-2011-2015/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>World TB Day!  Overview of Events, News and Messages</title>
		<link>http://www.newtbdrugs.org/blog/world-tb-day-overview-of-events-news-and-messages/</link>
		<comments>http://www.newtbdrugs.org/blog/world-tb-day-overview-of-events-news-and-messages/#comments</comments>
		<pubDate>Fri, 23 Mar 2012 18:53:40 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Action]]></category>
		<category><![CDATA[Announcements]]></category>
		<category><![CDATA[Events]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[advocacy]]></category>
		<category><![CDATA[children]]></category>
		<category><![CDATA[clinical trials]]></category>
		<category><![CDATA[crisis]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[pediatric]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[r&d]]></category>
		<category><![CDATA[stop tb]]></category>
		<category><![CDATA[tb alliance]]></category>
		<category><![CDATA[vaccines]]></category>
		<category><![CDATA[WHO]]></category>
		<category><![CDATA[world tb day]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3614</guid>
		<description><![CDATA[Saturday, March 24, is officially World TB Day but there has been a stream of activities, publications, news and messages to let the world not forget about this major infectious disease killer that claims millions of lives each year.  We present links and summaries of events, publications, messages, and news coverage leading up to World TB Day.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/world-tb-day-overview-of-events-news-and-messages/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>World TB Day Coverage: New Combo TB Drug Trial Announced</title>
		<link>http://www.newtbdrugs.org/blog/world-tb-day-coverage-new-combo-tb-drug-trial-announced/</link>
		<comments>http://www.newtbdrugs.org/blog/world-tb-day-coverage-new-combo-tb-drug-trial-announced/#comments</comments>
		<pubDate>Wed, 21 Mar 2012 17:12:21 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Announcements]]></category>
		<category><![CDATA[Events]]></category>
		<category><![CDATA[TB Drug Development]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[advocacy]]></category>
		<category><![CDATA[biomarkers]]></category>
		<category><![CDATA[clinical trials]]></category>
		<category><![CDATA[cptr]]></category>
		<category><![CDATA[diagnostics]]></category>
		<category><![CDATA[fda]]></category>
		<category><![CDATA[mdr]]></category>
		<category><![CDATA[nih/niaid]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[r&d]]></category>
		<category><![CDATA[tb alliance]]></category>
		<category><![CDATA[usaid]]></category>
		<category><![CDATA[vaccines]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3571</guid>
		<description><![CDATA[During the "Cure All: A briefing on the status of the most promising new TB drugs research" sponsored by the Critical Path to New TB Drug Regimens (CPTR) on Monday, March 19, Dr. Mel Spigelman, CEO &#038; President, of TB Alliance announced the launch of the NC002 trial, a combination drug trial that establishes a new pathway to TB and multi-drug resistant TB treatment. The meeting also involved high-level officials from U.S. agencies that support TB research including Anthony Fauci (Director, NIAID/NIH), Janet Woodcock (Director, CDER/FDA), and Robert Clay (Deputy Assistant Administrator, Global Health Bureau/USAID). ]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/world-tb-day-coverage-new-combo-tb-drug-trial-announced/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Death of TB Champion, Rep. Donald Payne</title>
		<link>http://www.newtbdrugs.org/blog/death-of-tb-champion-rep-donald-payne/</link>
		<comments>http://www.newtbdrugs.org/blog/death-of-tb-champion-rep-donald-payne/#comments</comments>
		<pubDate>Tue, 06 Mar 2012 17:54:43 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Announcements]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[advocacy]]></category>
		<category><![CDATA[funding]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[usa]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3546</guid>
		<description><![CDATA[U.S. Representative Donald Payne from New Jersey died Tuesday, March 6.  He will be remembered as a great champion of TB as well as malaria and HIV/AIDS.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/death-of-tb-champion-rep-donald-payne/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>News from the 21st Stop TB Partnership Coordinating Board Meeting, Bangkok</title>
		<link>http://www.newtbdrugs.org/blog/news-from-the-21st-stop-tb-partnership-coordinating-board-meeting-bangkok/</link>
		<comments>http://www.newtbdrugs.org/blog/news-from-the-21st-stop-tb-partnership-coordinating-board-meeting-bangkok/#comments</comments>
		<pubDate>Tue, 31 Jan 2012 19:37:16 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Action]]></category>
		<category><![CDATA[Announcements]]></category>
		<category><![CDATA[Events]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[advocacy]]></category>
		<category><![CDATA[clinical trials]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[South Africa]]></category>
		<category><![CDATA[stop tb]]></category>
		<category><![CDATA[TAG]]></category>
		<category><![CDATA[WHO]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3455</guid>
		<description><![CDATA[he 21st Stop TB Partnership Coordinating Board retreat and meeting officially started in Bangkok, Thailand, on Sunday, January 29th with the official opening ceremony held yesterday January 30th. Included are some exciting news from the meeting courtesy of Mark Harrington, Executive Director of the Treatment Action Group (TAG). ]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/news-from-the-21st-stop-tb-partnership-coordinating-board-meeting-bangkok/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Kick TB Campaign:  Scoring Big in South Africa and Beyond</title>
		<link>http://www.newtbdrugs.org/blog/kick-tb-campaign-scoring-big-in-south-africa-and-beyond/</link>
		<comments>http://www.newtbdrugs.org/blog/kick-tb-campaign-scoring-big-in-south-africa-and-beyond/#comments</comments>
		<pubDate>Wed, 18 Jan 2012 19:22:32 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Faces of TB]]></category>
		<category><![CDATA[TB Prevention and Control Strategies]]></category>
		<category><![CDATA[Video]]></category>
		<category><![CDATA[Voices from the Fight to Stop Tuberculosis]]></category>
		<category><![CDATA[advocacy]]></category>
		<category><![CDATA[children]]></category>
		<category><![CDATA[community]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[South Africa]]></category>
		<category><![CDATA[voices]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3403</guid>
		<description><![CDATA[The Kick TB Campaign is a unique project that uses the World's most popular sport to educate and engage young people in the effort to stop the spread of tuberculosis (TB).  ]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/kick-tb-campaign-scoring-big-in-south-africa-and-beyond/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TB R&amp;D Weekly Update:  Totally Drug-Resistant TB</title>
		<link>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-totally-drug-resistant-tb/</link>
		<comments>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-totally-drug-resistant-tb/#comments</comments>
		<pubDate>Fri, 13 Jan 2012 21:09:41 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[TB News]]></category>
		<category><![CDATA[TB Prevention and Control Strategies]]></category>
		<category><![CDATA[TB Treatment]]></category>
		<category><![CDATA[advocacy]]></category>
		<category><![CDATA[crisis]]></category>
		<category><![CDATA[endemic]]></category>
		<category><![CDATA[india]]></category>
		<category><![CDATA[mdr]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[totally drug resistant]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[WHO]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3394</guid>
		<description><![CDATA[Over the past couple of weeks there have been much discussion and reporting on totally drug-resistant tuberculosis (TDR-TB) based on reports of new cases in India.  Here are links to coverage of TDR-TB in India,  excerpt from a response by Dr. Nardell who we interviewed last year, and link to the WHO Fact Sheet on TDR-TB.  Additional links to TB R&#038;D News are included.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-totally-drug-resistant-tb/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>4th Annual G-FINDER Survey Released</title>
		<link>http://www.newtbdrugs.org/blog/4th-annual-g-finder-survey-released/</link>
		<comments>http://www.newtbdrugs.org/blog/4th-annual-g-finder-survey-released/#comments</comments>
		<pubDate>Thu, 08 Dec 2011 17:48:17 +0000</pubDate>
		<dc:creator>Heather_Ignatius</dc:creator>
				<category><![CDATA[Action]]></category>
		<category><![CDATA[Announcements]]></category>
		<category><![CDATA[Front Lines of TB R&D]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[advocacy]]></category>
		<category><![CDATA[diagnostics]]></category>
		<category><![CDATA[drug discovery]]></category>
		<category><![CDATA[funding]]></category>
		<category><![CDATA[global fund]]></category>
		<category><![CDATA[pdp]]></category>
		<category><![CDATA[policy]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[product development]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[r&d]]></category>
		<category><![CDATA[vaccines]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3364</guid>
		<description><![CDATA[Today, the fourth annual G-FINDER survey tracking funding for research and development of neglected disease technologies was released.  This year’s report shows that funding for product development is on the decline and product development partnerships (PDPs) have been particularly hard hit, as eight of the top twelve public donors cut their funding in 2010. Now is a time of tremendous opportunity, with dozens of potential products within the reach of patients--donors must commit to taking them across the finish line.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/4th-annual-g-finder-survey-released/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

